Search Results (29)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Pharmacovigilance | Concept |
Why?
|
| Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study. | Academic Article |
Why?
|
| Ivermectin associated adverse events in the treatment and prevention of COVID-19 reported to the FACT pharmacovigilance project. | Academic Article |
Why?
|
| Identification of Bradycardia Following Remdesivir Administration Through the US Food and Drug Administration American College of Medical Toxicology COVID-19 Toxic Pharmacovigilance Project. | Academic Article |
Why?
|
| Kao, David | Person |
Why?
|
| Reduced risk of suicidal behaviours associated with the treatment of hidradenitis suppurativa with tumour necrosis factor alpha antagonists: results from the US FDA Adverse Events Reporting System pharmacovigilance database. | Academic Article |
Why?
|
| Adverse event reporting in patients treated with levothyroxine: results of the pharmacovigilance task force survey of the american thyroid association, american association of clinical endocrinologists, and the endocrine society. | Academic Article |
Why?
|
| Clinically Inconsequential Alerts: The Characteristics of Opioid Drug Alerts and Their Utility in Preventing Adverse Drug Events in the Emergency Department. | Academic Article |
Why?
|
| Adverse drug event rates in pediatric pulmonary hypertension: a comparison of real-world data sources. | Academic Article |
Why?
|
| Variation of the prevalence of pediatric polypharmacy: A scoping review. | Academic Article |
Why?
|
| Enhancing Medication Safety in Children with Polypharmacy Using Parent-Reported Symptom Assessments | Grant |
Why?
|
| Cardiovascular disorders associated with naloxone monotherapy and in fixed-dose combination with opioids: Data from international safety surveillance. | Academic Article |
Why?
|
| Bonaca, Marc | Person |
Why?
|
| Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration. | Academic Article |
Why?
|
| Medication class enrichment analysis: a novel algorithm to analyze multiple pharmacologic exposures simultaneously using electronic health record data. | Academic Article |
Why?
|